Thailand’s PM says he won’t let Thais become vaccine “guinea pigs”
Thailand’s PM is saying he won’t let Thai people become vaccine “guinea pigs” in his Facebook post today as he points to reports of serious negative side effects that some people have suffered after getting jabbed with the Covid-19 vaccine. Instead, PM Prayut Chan-o-cha says he will wait for more information from the experts about whether such side effects were attributed to the vaccine solely, or other factors.
“For Thai people, I decided not to take the risk and will not rush to inoculate with vaccines which have not been fully tested and will not let Thai people become guinea pigs.”
He says the National Vaccine Committee will advise the government and closely supervise the use of Covid-19 vaccines in the country once they are rolled out. As the vaccines are not yet available, he reiterated the importance of taking precautions such as wearing face masks when leaving home, practising social distancing and abstaining from gatherings, particularly political ones.
The government has reported 374 new cases of Covid-19 in the kingdom today, with all but 10 being locally-transmitted. Now, the total has risen to 12,000 cases since the pandemic began.
A government spokesman is also saying that PM Prayut is worried about people’s health as the weather has taken a turn for the cold. He also affirmed the importance of imposing measures under the Emergency Decree and Thailand’s Communicable Disease Act in order to help curb the recent Covid second wave. He is also reminding the public to download the Thai Chana and Mor Chana apps.
Thailand has ordered 60 million doses of Covid-19 vaccines from a variety of sources, with the first shipment of 200,000 doses to arrive in February. Those vaccines are from China’s Sinovac Biotech. In March, another 800,000 doses are scheduled to arrive and another million by April.
The government has also pre-ordered 26 million doses of the Covid-19 vaccine from AstraZeneca, using vaccine technology transfer to allow local production by Thailand’s local company, Siam Bio Science.
SOURCE: Thai PBS World
